Why Iressa Tablet Is Used in EGFR-Positive Lung Cancer Treatment

Targeted therapy is a revolutionary treatment approach to treat a wide range of cancer. Iressa 250mg Tablet is one of the potent targeted therapy medicines that used to treat EGFR-positive non-small cell lung cancer (NSCLC). It is commonly prescribed to patients with advanced or metastatic lung cancer, especially when EGFR exon mutations confirmed. Unlike traditional chemotherapy that harms healthy cells also, it works by blocking the action of specific protein without harming healthy cells.

What Makes EGFR-Positive Lung Cancer Different?

These are the following factors that make this cancer different:

·         EGFR-positive NSCLC happens when a mutation activate the epidermal growth factor receptor and trigger the uncontrolled growth of abnormal cells.

·         This type of cancer responds well to EGFR-targeted therapies.

·         It is more common in non-smokers, women, as well as Asian populations.

·         Identifying the mutation through genetic testing helps doctors to choose and plan the most effective treatment approach.

How Iressa Helps

·         Improves treatment response: It effectively reduces the tumor's size and manages symptoms.

·         Oral targeted therapy: A convenient daily tablet.

·         Fewer side effects: More manageable side effects than chemotherapy.

·         Prevents tumor spread: Slows down metastasis by interrupting cell pathways.

·         Blocks EGFR signaling: This tablet inhibits the mutated receptor, stopping cancer cell growth.

Iressa 250mg Tablet Uses

·         EGFR-mutated NSCLC

·         First-line therapy in advanced or metastatic lung cancer.

·         Treatment option after chemotherapy failure

·         Maintenance therapy

Benefits of the tablet

·         Enhanced quality of life: Reduces cough, breathlessness, bone pain, and fatigue.

·         Precision-based treatment: Works only where the mutation is present.

·         Oral convenience: Helps patients continue treatment at home.

·         Improved progression-free survival in EGFR-positive patients.

·         Precision-based treatment: Works only where the mutation is present.

·         Better tolerance: Fewer severe side effects compared to chemotherapy.

Side Effects

Common:

·         Rash or acne

·         Diarrhea

·         Loss of appetite

·         Dry skin

·         Nausea

·         Weakness

Serious (rare):

·         Interstitial lung disease

·         Liver function abnormalities

·         Severe diarrhea or dehydration

Regular monitoring is essential during treatment to keep an eye on disease control or progress.

Price and Availability

·         Price of this tablet varies depending on the brand, manufacturer, and location.

·         Available at reliable oncology pharmacies that ensure genuine & well-stored life saving drugs.

·         Generic versions are usually more affordable.

·         Bulk purchase or online pharmacy services usually provide better pricing.

Conclusion

This medicine is a trusted and effective targeted therapy for EGFR-positive non-small cell lung cancer. It works by directly blocking the mutated EGFR pathway to slow down the cancer progression, reduce symptoms, and improve survival rate. You can buy Iressa 250mg Tablet online must visit the site of Magicine Pharma. It is the most trustworthy pharmacy to provide life saving drugs at a high discount price.

FAQ

Q-What is the use of Iressa 250mg? A-It is used to treat EGFR-mutated non-small cell lung cancer in adults.

Q-How do I know if I can take Iressa? A-A genetic test for EGFR mutations is required before starting treatment.

Q-Is Iressa tablet better than chemotherapy?

A-For EGFR-positive patients, Iressa often provides better outcomes and fewer side effects compared to chemotherapy.

Q-How long should I take this tablet? A-Patients usually take it daily until disease progression or unacceptable side effects occur.